Hotchkis & Wiley Capital Management
ELV icon

Hotchkis & Wiley Capital Management’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$552M Sell
1,418,442
-359,142
-20% -$140M 1.79% 11
2025
Q1
$773M Buy
1,777,584
+1,972
+0.1% +$858K 2.58% 6
2024
Q4
$655M Buy
1,775,612
+532,611
+43% +$196M 2.18% 7
2024
Q3
$646M Sell
1,243,001
-70,578
-5% -$36.7M 2.15% 8
2024
Q2
$712M Sell
1,313,579
-186,960
-12% -$101M 2.48% 7
2024
Q1
$778M Sell
1,500,539
-113,791
-7% -$59M 2.59% 7
2023
Q4
$761M Sell
1,614,330
-108,477
-6% -$51.2M 2.71% 5
2023
Q3
$750M Buy
1,722,807
+133,453
+8% +$58.1M 2.85% 6
2023
Q2
$706M Buy
1,589,354
+298,562
+23% +$133M 2.62% 5
2023
Q1
$594M Buy
1,290,792
+492,237
+62% +$226M 2.29% 8
2022
Q4
$410M Sell
798,555
-279,687
-26% -$143M 1.57% 18
2022
Q3
$490M Sell
1,078,242
-164,088
-13% -$74.5M 2.1% 10
2022
Q2
$600M Sell
1,242,330
-478,177
-28% -$231M 2.38% 8
2022
Q1
$845M Sell
1,720,507
-376,181
-18% -$185M 2.69% 6
2021
Q4
$972M Sell
2,096,688
-286,740
-12% -$133M 3.06% 5
2021
Q3
$889M Sell
2,383,428
-68,916
-3% -$25.7M 2.84% 5
2021
Q2
$936M Sell
2,452,344
-156,294
-6% -$59.7M 2.85% 5
2021
Q1
$936M Buy
2,608,638
+300,302
+13% +$108M 2.85% 5
2020
Q4
$741M Buy
2,308,336
+252,647
+12% +$81.1M 2.59% 6
2020
Q3
$552M Buy
2,055,689
+388,905
+23% +$104M 2.51% 7
2020
Q2
$438M Buy
1,666,784
+5,890
+0.4% +$1.55M 2.04% 10
2020
Q1
$377M Buy
1,660,894
+396,620
+31% +$90M 2.12% 10
2019
Q4
$382M Buy
1,264,274
+96,973
+8% +$29.3M 1.33% 26
2019
Q3
$280M Buy
1,167,301
+309,390
+36% +$74.3M 1.13% 32
2019
Q2
$242M Buy
857,911
+292,610
+52% +$82.6M 0.93% 39
2019
Q1
$162M Sell
565,301
-18,469
-3% -$5.3M 0.64% 45
2018
Q4
$153M Sell
583,770
-612,522
-51% -$161M 0.68% 45
2018
Q3
$328M Sell
1,196,292
-108,584
-8% -$29.8M 1.18% 30
2018
Q2
$311M Sell
1,304,876
-26,925
-2% -$6.41M 1.17% 30
2018
Q1
$293M Sell
1,331,801
-134,917
-9% -$29.6M 1.16% 34
2017
Q4
$330M Sell
1,466,718
-927,092
-39% -$209M 1.25% 26
2017
Q3
$455M Buy
2,393,810
+12,975
+0.5% +$2.46M 1.79% 16
2017
Q2
$448M Sell
2,380,835
-1,169,135
-33% -$220M 1.8% 16
2017
Q1
$587M Sell
3,549,970
-85,597
-2% -$14.2M 2.3% 10
2016
Q4
$523M Sell
3,635,567
-71,746
-2% -$10.3M 2.11% 10
2016
Q3
$465M Buy
3,707,313
+1,241,762
+50% +$156M 1.94% 12
2016
Q2
$324M Buy
2,465,551
+176,293
+8% +$23.2M 1.38% 24
2016
Q1
$318M Sell
2,289,258
-94,128
-4% -$13.1M 1.34% 24
2015
Q4
$332M Buy
2,383,386
+58,018
+2% +$8.09M 1.35% 23
2015
Q3
$326M Buy
2,325,368
+869,193
+60% +$122M 1.3% 26
2015
Q2
$239M Sell
1,456,175
-831,182
-36% -$136M 0.84% 43
2015
Q1
$353M Sell
2,287,357
-418,979
-15% -$64.7M 1.23% 27
2014
Q4
$340M Buy
2,706,336
+17,920
+0.7% +$2.25M 1.19% 28
2014
Q3
$322M Sell
2,688,416
-828,772
-24% -$99.1M 1.17% 28
2014
Q2
$378M Buy
3,517,188
+220,501
+7% +$23.7M 1.34% 26
2014
Q1
$328M Buy
3,296,687
+281,541
+9% +$28M 1.22% 29
2013
Q4
$279M Sell
3,015,146
-94,133
-3% -$8.7M 1.19% 30
2013
Q3
$260M Sell
3,109,279
-48,620
-2% -$4.07M 1.2% 29
2013
Q2
$258M Buy
+3,157,899
New +$258M 1.29% 29